Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis

被引:70
作者
Arness, T. [2 ]
Pedersen, R. [3 ]
Dierkhising, R. [3 ]
Kremers, W. [3 ]
Patel, R. [1 ,4 ]
机构
[1] Mayo Clin, Coll Med, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin, Mayo Med Sch, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Hlth Sci Res, Div Biostat, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA
关键词
varicella; herpes zoster; shingles; kidney transplant;
D O I
10.1111/j.1399-3062.2007.00289.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Varicella zoster virus (VZV)-related disease, particularly herpes zoster, is a complication of organ transplantation due to long-term immunosuppression. We determined the incidence and risk factors for post-transplant VZV infection by retrospectively reviewing the medical records of a cohort of 612 adult renal transplant recipients transplanted at Mayo Clinic Rochester between October 1, 2001 and October 1, 2004. Thirty-seven subjects developed herpes zoster, corresponding to a follow-up time-adjusted incidence of 11.2% at 4 years post transplant. The incidence rate of zoster was relatively constant between 6 months and 4 years, yielding an average incidence of approximately 28 per 1000 person-years. The risk of developing post-transplant zoster increased with increasing age at transplant, with each decade conferring a 1.42-fold (P = 0.009) increase in risk of zoster development. Seronegativity at time of transplant conferred over 3 times the risk of development of post-transplant zoster (hazard ratio 3.4; P = 0.04) compared with seropositivity. Adult kidney transplant recipients are at high risk for the development of post-transplant zoster.
引用
收藏
页码:260 / 268
页数:9
相关论文
共 22 条
[1]   Aging, immunity, and the varicella-zoster virus [J].
Arvin, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22) :2266-2267
[2]   Health status ten years after pediatric liver transplantation - Looking beyond the graft [J].
Avitzur, Y ;
De Luca, E ;
Cantos, M ;
Jimenez-Rivera, C ;
Jones, N ;
Fecteau, A ;
Grant, D ;
Ng, VL .
TRANSPLANTATION, 2004, 78 (04) :566-573
[3]  
BROYER M, 1985, POSTGRAD MED J, V61, P103
[4]   The incidence of shingles and its implications for vaccination policy [J].
Chapman, RS ;
Cross, KW ;
Fleming, DM .
VACCINE, 2003, 21 (19-20) :2541-2547
[5]   Response to varicella immunization in pediatric liver transplant recipients [J].
Donati, M ;
Zuckerman, M ;
Dhawan, A ;
Hadzic, N ;
Heaton, N ;
North-Lewis, P ;
Mieli-Vergani, G .
TRANSPLANTATION, 2000, 70 (09) :1401-1404
[6]   Successful vaccination against varicella zoster virus prior to kidney transplantation [J].
Geel, A ;
Zuidema, W ;
van Gelder, T ;
van Doornum, G ;
Weimar, W .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :952-953
[7]  
GIACCHINO R, 1995, TRANSPLANTATION, V60, P1055
[8]   Herpes zoster infection following solid organ transplantation: Incidence, risk factors and outcomes in the current immunosuppressive era [J].
Gourishankar, S ;
McDermid, JC ;
Jhangri, GS ;
Preiksaitis, JK .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (01) :108-115
[9]   Herpes zoster after liver transplantation: Incidence, risk factors, and complications [J].
Herrero, JI ;
Quiroga, J ;
Sangro, B ;
Pardo, F ;
Rotellar, F ;
Alvarez-Cienfuegos, J ;
Prieto, J .
LIVER TRANSPLANTATION, 2004, 10 (09) :1140-1143
[10]   Skin infections in renal transplant recipients [J].
Hogewoning, AA ;
Goettsch, W ;
van Loveren, H ;
de Fijter, JW ;
Vermeer, BJ ;
Bavinck, JNB .
CLINICAL TRANSPLANTATION, 2001, 15 (01) :32-38